GRUSF 10-K & 10-Q changes, risk factors and insider trading
Grown Rogue International Inc. · OTC · Agricultural Production-Crops · CIK 1463000 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
There have been no material changes from the risk factors as previously disclosed in the Annual Report.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“Total other income (expense), net was ($1,796,175) for the three months ended March 31, 2026 as compared to $2,083,581 for the three months ended March 31, 2025, a decrease of $3,879,756. …”see in full comparison
“The year-over-year changes were driven principally by unrealized losses on the Vireo Growth warrant asset of $556,583 in the current quarter and $2,747,667 year-to-date (as compared to unrealized losses of $168,162 and $1,340,654, respectively, in the prior-year periods), reflecting the decline in Vireo Growth’s share price, and by the absence in 2026 of the large realized and unrealized loss on the convertible-debenture derivative liability recognized in 2025 upon the extinguishment of the convertible debentures. …”see in full comparison
“All revenue for the three and six months ended June 30, 2026 and 2025 was earned from product sales of cannabis flower and pre-roll products. Total revenue for the three months ended June 30, 2026 was $11,273,837, an increase of $3,263,850 or approximately 41% as compared to $8,009,987 for the three months ended June 30, 2025. For the six months ended June 30, 2026, total revenue was $20,429,495, an increase of $5,269,325 or approximately 35% as compared to $15,160,170 for the six months ended June 30, 2025. …”see in full comparison
see in full comparisonContractual maturities of long-term debt asAs ofMarchJune31,30,2026 are approximately $3,941,000 due within one year, $3,669,000 due in years two through three, and $7,937,000 due thereafter, totaling undiscounted long-term debt obligations of approximately $15,547,000, less unamortized interest of approximately $2,865,262, for a2026, total long-term debt was approximately $12,733,162 (comprising a current portion of $3,002,684 and a non-current portion of $9,730,478), as compared to $12,682,124 at March 31, 2026. Total long term debt payments are approximately $15,510,053 (consisting of $2,453,014 for the remainder of 2026, $3,815,153 in 2027, $2,934,466 in 2028, and $6,307,420 in 2029), less unamortized interest of approximately $2,776,891, resulting in a total long term debt liability of$12,682,124.approximately $12,733,162. For a complete description of the Company’s debt obligations, refer to Note 11 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
“Total operating expenses for the three months ended March 31, 2026 were $3,857,980, a decrease of $215,168 or approximately 5% as compared to $4,073,148 for the three months ended March 31, 2025. …”see in full comparison
“Equity Incentive Awards. On July 21, 2026, the Company’s board of directors approved the grant of 400,000 stock options and 2,490,000 restricted share units (“RSU’s”) to directors, officers and employees, and reserved 2,890,000 SV Shares for issuance in respect of these awards. The stock options have an exercise price of $0.42 (CAD$0.60) and expire on July 21, 2030. The options vest as to 50% on June 30, 2027 and 50% on June 30, 2028. …”see in full comparison
Full comparison: every changed paragraph (43)
In addition to events discussed elsewhere in this Quarterly Report, the following developments occurred during, or have a direct bearing on, the three and six months ended MarchJune 31,30, 2026:
Stock option exercise. On January 12,
2026, the Company issued 200,000 SV Shares pursuant to the exercise of stock options for total proceeds of approximately $21,615 (CAD$30,000).
As a result, total SV Shares issued and outstanding increased from 249,738,980 at December 31, 2025 to 249,938,980 on March 31, 2026.
Illinois expansion. On March 12, 2026, the Company announced that it had taken operational control of a cannabis production facility in Dwight, Illinois, through its affiliatesaffiliate Grown Rogue Management Associates, LLC (“GRMA”), an 80% owned subsidiary of the Company, and entered into a Membership Interest Purchase Agreement to acquire a 49% interest in SEA Craft, the holder of an Illinois Adult Use Cannabis Craft Grower License. The agreement provides GRMA with an option, subject to regulatory approval and performance-based conditions, to acquire the remaining 51% of SEA Craft, and concurrently grants the holder of those remaining interests an option, subject to certain conditions precedent, to require GRMA to purchase those remaining interests. The transaction is subject to regulatory approval by the Illinois Department of Agriculture,Agriculture. and asAs of MarchJune 31,30, 20262026, the status of the required regulatory approvals required to consummateand the transactionclosing had not been obtained, and accordingly,of the acquisitionSEA had not closed. The Company expects theCraft acquisition toremain close in the second quarter of 2026.outstanding.
ABCO Phase II construction. As previously
disclosed in our Annual Report, on December 8, 2025, ABCO entered into an agreement with Blackwell & Associates (“Blackwell”)
for the construction of the Grandview Phase II project located at 1425 Grandview Avenue, Paulsboro, New Jersey, on a cost-plus-a-fee
basis without a guaranteed maximum price. The total estimated cost is approximately $1,430,000, which includes the cost of the work plus
Blackwell’s fee, subject to adjustments under the contract documents. Construction continued duringthrough the threedate monthsof endedthis March 31,
2026.report. Blackwell is considered a related party as it is controlled by the spouse of the majority owner of ABCO Holdings.Garden State, LLC.
Reclassification of warrants to derivative
liability. As a result of the change in functional currency described above, 4,000,000 warrants previously classified within shareholders’
equity no longer met the criteria for equity classification under U.S. GAAP and were reclassified to a derivativewarrant liability measured at
fair value, with subsequent changes in fair value recognized through profit or loss. On January 1, 2026, the Company recognized $1,539,665
of warrant liability with a corresponding decrease in share capital. During the threesix months ended MarchJune 31,30, 2026, the Company recorded
an a net unrealized gain of $770,714$433,547 on changes in the fair value of the warrant liability,liability (comprising an unrealized gain of $770,714 in the first quarter and an unrealized loss of $337,167 in the second quarter), resulting in a warrant liability balance of $768,951
$1,106,118 at MarchJune 31,30, 2026. For further discussion, see Note 13.212.2 to the unaudited condensed consolidated financial statements included elsewhere
in this Quarterly Report on Form 10-Q.
Stock option exercise. On January 12, 2026, the Company issued 200,000 SV Shares pursuant to the exercise of stock options for total proceeds of approximately $21,615 (CAD$30,000). As a result, total SV Shares issued and outstanding increased from 249,738,980 at December 31, 2025 to 249,938,980 on June 30, 2026.
Equity Incentive Awards. On July 21, 2026, the Company’s board of directors approved the grant of 400,000 stock options and 2,490,000 restricted share units (“RSU’s”) to directors, officers and employees, and reserved 2,890,000 SV Shares for issuance in respect of these awards. The stock options have an exercise price of $0.42 (CAD$0.60) and expire on July 21, 2030. The options vest as to 50% on June 30, 2027 and 50% on June 30, 2028. The RSUs vest as follows: 100,000 on January 1, 2027; 150,000 on June 30, 2028; 1,240,000 on January 1, 2029; and 1,000,000 in three equal annual tranches on January 1 of 2027, 2028 and 2029. Certain of the awards provide for immediate vesting upon termination of the holder’s engagement with the Company.
Comparison of the Three and Six Months Ended MarchJune 31,30, 2026 and 2025
Significant items contributing to the change in net income (loss) are summarized below.
Significant items contributing to the change in net income (loss) are summarized below. Total revenue for the three months ended March 31, 2026 was $9,155,658, an increase of $2,005,475 or approximately 28% as compared to $7,150,183 for the three months ended March 31, 2025. The increase in revenue was driven by continued growth at our New Jersey operations, which contributed $3,415,367 to revenue in the current quarter as compared to $1,771,720 in the prior-year quarter, supplemented by year-over-year growth in the Oregon and Michigan operations.
All revenue for the three and six months ended June 30, 2026 and 2025 was earned from product sales of cannabis flower and pre-roll products. Total revenue for the three months ended June 30, 2026 was $11,273,837, an increase of $3,263,850 or approximately 41% as compared to $8,009,987 for the three months ended June 30, 2025. For the six months ended June 30, 2026, total revenue was $20,429,495, an increase of $5,269,325 or approximately 35% as compared to $15,160,170 for the six months ended June 30, 2025. The increase in revenue was driven primarily by continued growth at our New Jersey operations, which contributed $4,369,698 to revenue in the current quarter (as compared to $2,655,954 in the prior-year quarter) and $7,785,066 for the year-to-date period (as compared to $4,427,674 in the prior-year period), supplemented by year-over-year growth in the Oregon and Michigan operations.
All revenue for the three months ended March 31, 2026 and 2025 was earned from product sales of cannabis flower and pre-roll products. No service revenue was recorded in either period, consistent with the termination of the Vireo Growth consulting agreement in October 2024.
Cost of finished cannabis inventory sold for the
three months ended MarchJune 31,30, 2026 was $5,198,024,$5,903,860, an increase of $1,411,588$1,448,358 or approximately 37%33% as compared to $3,786,436$4,455,502 for the
three months ended MarchJune 31,30, 2025. For the six months ended June 30, 2026, cost of finished cannabis inventory sold was $11,101,884, an increase of $2,859,946 or approximately 35% as compared to $8,241,938 for the six months ended June 30, 2025. Cost of revenues grew at a rate faster than the rate of revenue growth (28%), largely due to mix
and higher operating lease costs includedbroadly in costline ofwith sales.revenue, reflecting product and market mix.
Gross profit for the three months ended June 30, 2026 was $5,369,977 (a gross margin of approximately 48%), an increase of $1,815,492 or approximately 51% as compared to $3,554,485 for the three months ended June 30, 2025 (a gross margin of approximately 44%). For the six months ended June 30, 2026, gross profit was $9,327,611 (a gross margin of approximately 46%), an increase of $2,409,379 or approximately 35% as compared to $6,918,232 for the six months ended June 30, 2025 (a gross margin of approximately 46%).
Gross profit for the three months ended March 31, 2026 was $3,957,634, an increase of $593,887 or approximately 18% as compared to $3,363,747 for the three months ended March 31, 2025.
Total operating expenses for the three months ended June 30, 2026 were $4,533,321, an increase of $1,410,197 or approximately 45% as compared to $3,123,124 for the three months ended June 30, 2025. For the six months ended June 30, 2026, total operating expenses were $8,391,300, an increase of $1,195,028 or approximately 17% as compared to $7,196,272 for the six months ended June 30, 2025.
The three months ended June 30, 2026 increase was driven principally by higher general and administrative expenses ($4,318,584 for the three months ended June 30, 2026 as compared to $2,678,372 in the prior-year quarter) reflecting headcount and infrastructure additions in support of growth and expansion activities, partially offset by lower share-based compensation expense ($149,087 for the three months ended June 30 2026 as compared to $336,825 in the prior-year quarter) reflecting the timing of restricted share unit and stock option vesting and lower depreciation expense ($65,650 for the three months ended June 30 2026 as compared to $107,927 in the prior-year quarter).
The year-to-date increase was driven principally by higher general and administrative expenses ($7,930,407 for the six months ended June 30, 2026 as compared to $5,210,626 for the prior-year period), reflecting headcount and infrastructure additions in support of growth and expansion activities, together with certain Golden Harvests-related taxes, partially offset by lower share-based compensation expense ($304,081 for the six months ended June 30, 2026 as compared to $1,772,735 for the prior-year period), reflecting the timing of restricted share unit and stock option vesting and lower depreciation expense ($156,812 for the six months ended June 30, 2026 as compared to $212,911 for the prior-year period).
Total operating expenses for the three months
ended March 31, 2026 were $3,857,980, a decrease of $215,168 or approximately 5% as compared to $4,073,148 for the three months ended
March 31, 2025. The decrease was driven principally by lower share-based compensation expense ($154,994 in the current quarter as
compared to $1,435,910 in the prior-year quarter, reflecting the timing of restricted share unit vesting) and lower depreciation expense
($91,162 in the current quarter as compared to $104,984 in the prior-year quarter), partially offset by an increase in general and administrative
expenses to $3,611,824 in the current quarter as compared to $2,532,254 in the prior-year quarter, reflecting headcount and infrastructure
additions in support of growth and expansion activities.
Total other income (expense) was and expense of $1,446,349 for the three months ended June 30, 2026 as compared to income of $2,144,054 for the three months ended June 30, 2025, and was an expense of $3,242,524 for the six months ended June 30, 2026 as compared to income of $4,227,634 for the six months ended June 30, 2025.
The year-over-year changes were driven principally by unrealized losses on the Vireo Growth warrant asset of $556,583 in the current quarter and $2,747,667 year-to-date (as compared to unrealized losses of $168,162 and $1,340,654, respectively, in the prior-year periods), reflecting the decline in Vireo Growth’s share price, and by the absence in 2026 of the large realized and unrealized loss on the convertible-debenture derivative liability recognized in 2025 upon the extinguishment of the convertible debentures. These were partially offset by an unrealized gain on the reclassified warrant liability of $433,547 year-to-date and by higher interest income of $104,356 in the current quarter and $146,543 year-to-date (as compared to $36,337 and $72,274, respectively). Interest and accretion expense was $429,240 in the current quarter and $979,220 year-to-date (as compared to $432,553 and $690,724, respectively), with the year-to-date increase reflecting the larger average outstanding balance under the Western Alliance Bank credit facility.
Total other income (expense), net was ($1,796,175) for the three months ended March 31, 2026 as compared to $2,083,581 for the three months ended March 31, 2025, a decrease of $3,879,756. The current-quarter result was driven principally by a $2,191,084 unrealized loss on the Vireo Growth warrant asset (compared to a $1,172,492 unrealized loss in the prior-year quarter) reflecting the decline in Vireo Growth’s share price during the period, partially offset by a $770,714 unrealized gain on the warrant liability that was reclassified from equity on January 1, 2026 in connection with the functional currency change, and a $66,377 unrealized gain on the Western Alliance Bank interest rate swap derivative. Interest and accretion expense was $549,980 in the current quarter as compared to $258,171 in the prior-year quarter, reflecting the larger outstanding balance under the Western Alliance Bank credit facility.
Income tax expense for the three months ended
March 31, 2026 was $516,871, with a corresponding effective tax rate of approximately 30.5%, as compared to $631,310 and an effective
tax rate of approximately (46%) (on pre-tax income)$871,331 for the three months ended MarchJune 31,30, 2026 as compared to income of $920,037 for the three months ended June 30, 2025. Income tax expense was $1,388,202 for the six months ended June 30, 2026, as compared to $1,551,347 for the six months ended June 30, 2025. The effective tax rate continues to
be heavily influenced by the Company’s uncertain tax positions related to the treatment of certain transactions and deductions under
Section 280E of the Internal Revenue Code. As at MarchJune 31,30, 2026, the uncertain tax liability totaled $9,280,905 (December 31,
2025 - $8,383,888),liability, inclusive of penalties and interest, was approximately $9,830,257 (December 31, 2025 - $8,383,888) and is included in other non-current liabilities.
Net loss for the three months ended MarchJune 31,30,
2026 was ($2,213,391)$1,481,024, as compared to net income of $742,870$1,655,378 for the three months ended MarchJune 31,30, 2025. NetFor the six months ended June
30, 2026, net loss attributable to shareholders
was ($2,702,217) for the current quarter$3,694,415 as compared to net income attributable to shareholders of $598,782$2,398,248 for the prior-yearsix quarter.months ended June 30, 2025. Net loss attributable
to shareholders was $1,692,836 for the current quarter and $4,395,053 year-to-date, with net income attributable to non-controlling interests
of $211,812 and $700,638, respectively.
The Company operates in three reportable segments -– Oregon, Michigan, and New Jersey -– with general corporate and administrative expenses included within “Corporate” to reconcile the reportable segments to the financial statements. The following summarizes performance by segment for the three and six months ended MarchJune 31,30, 2026 and 2025:
For the three months ended MarchJune 31,30, 2026: net revenue of $2,996,764$3,511,544 (Oregon), $2,743,527$3,392,595 (Michigan), and $3,415,367$4,369,698 (New Jersey); gross profit of $551,164$1,209,207 (Oregon), $1,325,262$1,586,755 (Michigan), and $2,081,208$2,574,015 (New Jersey); and net income (loss) of $64,417$459,258 (Oregon), $349,578$439,146 (Michigan), $1,044,791$1,559,291 (New Jersey), and $(3,676,1773,938,719) (Corporate).
For the three months ended MarchJune 31,30, 2025: net revenue of $2,873,347$3,075,599 (Oregon), $2,505,116$2,278,434 (Michigan), and $1,771,720$2,655,954 (New Jersey); gross profit of $1,303,832$1,069,878 (Oregon), $1,129,086$1,020,427 (Michigan), and $930,829$1,464,180 (New Jersey); and net income (loss) of $682,024$453,385 (Oregon), $508,656$467,694 (Michigan), $709,263$851,533 (New Jersey), and $(1,157,073117,234) (Corporate). Michigan segment revenue includes approximately $402,309 of excise taxes collected following the implementation of Michigan’s cannabis excise tax effective January 1, 2026.
For the six months ended June 30, 2026: net revenue of $6,508,307 (Oregon), $6,136,122 (Michigan), and $7,785,066 (New Jersey); gross profit of $1,760,370 (Oregon), $2,912,018 (Michigan), and $4,655,223 (New Jersey); and net income (loss) of $538,327 (Oregon), $788,724 (Michigan), $2,604,114 (New Jersey), and $(7,625,580) (Corporate).
For the six months ended June 30, 2025: net revenue of $5,948,946 (Oregon), $4,783,550 (Michigan), and $4,427,674 (New Jersey); gross profit of $2,373,710 (Oregon), $2,149,513 (Michigan), and $2,395,009 (New Jersey); and net income (loss) of $1,135,409 (Oregon), $976,350 (Michigan), $1,560,796 (New Jersey), and $(1,274,307) (Corporate). Michigan segment revenue for the six-month period includes approximately $748,242 of Michigan cannabis excise taxes.
All revenue for the three and six months ended MarchJune 31,30, 2026 and 2025 was earned in the United States. For the three and six months ended MarchJune 31,30, 2026 and 2025, no customer represented more than 10% of the Company’s net revenue, and as at MarchJune 31,30, 2026 and December 31, 2025, no customer represented more than 10% of the Company’s accounts receivable.
The following table provides a reconciliation of net income (loss), as reported, to EBITDA and Adjusted EBITDA (non-GAAP) for the three and six months ended MarchJune 31,30, 2026 and 2025:
We believe that our cash on hand at MarchJune 31,30, 2026, projected cash flows from current and future anticipated sales of finished goods, and net proceeds from current and anticipated financing activities, will be sufficient to meet our liquidity and capital resource requirements for the next twelve months from the date of issuance of this Quarterly Report on Form 10-Q.
At MarchJune 31,30, 2026 and December 31, 2025, our working capital was approximately $17,394,336$14,940,478 and $16,590,979, respectively, calculated as current assets less current liabilities (excluding the derivative liability and, for the current period,and the warrant liabilities, in each case representing non-cash fair value items). Cash and cash equivalents were $13,701,247$11,532,826 at MarchJune 31,30, 2026 as compared to $11,371,834 at December 31, 2025. Total current assets were $24,855,479$22,554,876 at MarchJune 31,30, 2026 as compared to $22,178,714 at December 31, 2025, with the increase reflecting growth in cash and cash equivalents and accounts receivable.2025.
Total current liabilities were $8,300,758$8,709,174 at MarchJune 31,30, 2026 as compared to $5,724,776 at December 31, 2025, with the increase reflecting growth in accounts payable and accrued liabilities ($2,731,607$2,544,834 at MarchJune 31,30, 2026 as compared to $1,262,519 at December 31, 2025), anda higher current portion of long-term debt ($3,002,684 as compared to $2,576,228), the reclassification of $768,951 of warrant liabilities fromof non-current liabilities$1,106,118 to current liabilities effective January 1, 2026 in connection with the change in functional currency, partiallyand offsetan by a slight decreaseincrease in income tax payable to $286,980$412,770 at MarchJune 31,30, 2026 (December 31, 2025 - $296,018).
Cash and cash equivalents increased by $2,329,413$160,992 during the threesix months ended MarchJune 31,30, 2026 to $13,701,247,$11,532,826, as compared to an increase of $4,914,717$4,681,969 during the threesix months ended MarchJune 31,30, 2025 (from $4,917,708 at January 1, 2025 to $9,832,425$9,599,677 at MarchJune 31,30, 2025).
Net cash provided by operating activities was $2,534,524$4,247,865 for the threesix months ended MarchJune 31,30, 2026, as compared to net cash used in operating activities of ($1,004,580)$656,881 for the threesix months ended MarchJune 31,30, 2025. The current-quartercurrent-period result reflects operating profitability and approximately $1,939,688$2,280,732 in favorable changes in non-cash working capital, principally driven by an increaseincreases in accounts payable and accrued liabilities of $1,469,088 and an increase in the uncertain tax position liability of $897,017,liability, partially offset by an increase in accounts receivable and a slight decrease in income tax payable.receivable.
Net cash used in
investing activities was ($2,874,613)$6,291,761 for the threesix months ended MarchJune 31,30, 2026, as compared to $(333,822)$964,360 for the threesix months
ended MarchJune 31,30, 2025. The current-quartercurrent-period use was driven principally by $2,517,414$5,498,773 in property and equipment additions
(as compared to $241,532 in the prior-year quarterperiod), supporting the build-out of cultivation capacity at ABCO Garden State, LLC through
the Grandview Phase II project,project and the Company’s ongoing buildexpansion outactivities, intogether Minnesota,with $200,000$415,000 inadvanced investmentson intothe purchase of the remaining Rogue EBC, LLC
equity interest,interest and $157,199$377,988 in payments of business acquisition consideration payable.
Net cash provided by financing activities was $2,669,413$2,204,888 for the threesix months ended MarchJune 31,30, 2026, as compared to $6,245,287$6,301,925 for the threesix months ended MarchJune 31,30, 2025. Significant financing activities for the current quarterperiod included: net proceeds of $2,985,000 from the sale of a 20% non-controlling interest in GRMA (gross proceeds of $3,000,000 less $15,000 of issuance costs); $1,000,000 in proceeds from long-term debt; $21,839 in proceeds from stock option exercises; $500,000 in proceeds from long-term debt; $743,460$1,529,295 in repayment of long-term debt; and$37,500 in repayment of finance leases; and $85,156$235,156 of distributions to the non-controlling interests in subsidiaries (combining $28,356 of GRMA preferred return distributions and $56,800 of dividends paid by Golden Harvests, LLC to its non-controlling interest holder).subsidiaries.
As of MarchJune 31,30, 2026, the Company believes it was in compliance with all financial covenants under the Credit Facility, including the fixed charge coverage ratio and leverage ratio (each as defined therein).
For a complete description of our
long-term debt, convertible debentures, derivative liability, and consideration payable on business acquisitions, refer to Notes 13,
14, 15, and 16 to the audited consolidated financial statements included in our Annual Report, and to Notes 11, 12,11 and 1312 in the unaudited condensed consolidated financial statements included elsewhere in
this Quarterly Report on Form 10-Q.
Set out below are undiscounted minimum future
lease payments after MarchJune 31,30, 2026 based on the Company’s operating and finance leases. Total operating lease payments are approximately $28,221,812
$27,633,880 (consisting of $2,138,920$1,312,195 infor the remainder of 2026, $2,710,116$2,751,620 in 2027, $2,800,069$2,791,191 in 2028, $2,893,248$2,883,971 in 2029, $2,503,747 $2,494,052
in 2030, and $15,175,712$15,400,851 thereafter), less unamortized interest of approximately $13,637,899,$13,209,345, resulting in a total operating lease liability
of approximately $14,583,913.$14,424,535. Total finance lease payments are approximately $235,000$216,374 (consisting of $161,250$142,500 infor the remainder of 2026
and $73,874 in 2027), less unamortized interest of approximately $25,000,$17,590, resulting in a total finance lease liability of approximately $210,000. The increase in operating lease obligations from December 31, 2025 primarily reflects the impact of signed lease extensions with the CEO for the Lars property quartering April of 2026.
$198,784.
Contractual maturities
of long-term debt asAs of MarchJune 31,30, 2026 are approximately $3,941,000 due within one year, $3,669,000 due in years two through three,
and $7,937,000 due thereafter, totaling undiscounted long-term debt obligations of approximately $15,547,000, less unamortized interest
of approximately $2,865,262, for a2026, total long-term debt was approximately $12,733,162 (comprising a current portion of $3,002,684 and a non-current portion of $9,730,478), as compared to $12,682,124 at March 31, 2026. Total long term debt payments are approximately $15,510,053 (consisting of $2,453,014 for the remainder of 2026, $3,815,153 in 2027, $2,934,466 in 2028, and $6,307,420 in 2029), less unamortized interest of approximately $2,776,891, resulting in a total long term debt liability of $12,682,124.approximately $12,733,162. For a complete description of the Company’s debt
obligations, refer to Note 11 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly
Report on Form 10-Q.
During the three and six months ended MarchJune 31,30, 2026 and 2025, we did not have, nor do we currently have, any off-balance sheet arrangements as defined in the applicable rules and regulations of the SEC.
GRUSF insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 1 filing (1 insider, 1 trade date, 1,400 shares, about $602). Net open-market shares: -1,400 (purchases minus sales); net value about -$602.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-22 | Marchington Andrew |
Open-market sale | 1,400 | $0.43 | $602 |
Well-known investors holding GRUSF (13F)
None of the 59 investors we track reported a position in their latest 13F.